|
1
|
Lengyel E: Ovarian cancer development and
metastasis. Am J Pathol. 177:1053–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iwatsuki M, Mimori K, Yokobori T, et al:
Epithelial-mesenchymal transition in cancer development and its
clinical significance. Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Condeelis J and Segall JE: Intravital
imaging of cell movement in tumours. Nat Rev Cancer. 3:921–930.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nisticò P, Bissell MJ and Radisky DC:
Epithelial-mesenchymal transition: general principles and
pathological relevance with special emphasis on the role of matrix
metalloproteinases. Cold Spring Harb Perspect Biol. 4:2012.
|
|
6
|
Birchmeier W and Behrens J: Cadherin
expression in carcinomas: role in the formation of cell junctions
and the prevention of invasiveness. Biochim Biophys Acta.
1198:11–26. 1994.PubMed/NCBI
|
|
7
|
Elloul S, Elstrand MB, Nesland JM, et al:
Snail, Slug, and Smad-interacting protein 1 as novel parameters of
disease aggressiveness in metastatic ovarian and breast carcinoma.
Cancer. 103:1631–1643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin H, Yu Y, Zhang T, et al: Snail is
critical for tumor growth and metastasis of ovarian carcinoma. Int
J Cancer. 126:2102–2111. 2010.PubMed/NCBI
|
|
9
|
Ahmed N, Thompson EW and Quinn MA:
Epithelial-mesenchymal interconversions in normal ovarian surface
epithelium and ovarian carcinomas: an exception to the norm. J Cell
Physiol. 213:581–588. 2007. View Article : Google Scholar
|
|
10
|
Jiang H, Lin X, Liu Y, et al:
Transformation of epithelial ovarian cancer stemlike cells into
mesenchymal lineage via EMT results in cellular heterogeneity and
supports tumor engraftment. Mol Med. 18:1197–1208. 2012. View Article : Google Scholar
|
|
11
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elloul S, Vaksman O, Stavnes HT, Trope CG,
Davidson B and Reich R: Mesenchymal-to-epithelial transition
determinants as characteristics of ovarian carcinoma effusions.
Clin Exp Metastasis. 27:161–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wells A, Yates C and Shepard CR:
E-cadherin as an indicator of mesenchymal to epithelial reverting
transitions during the metastatic seeding of disseminated
carcinomas. Clin Exp Metastasis. 25:621–628. 2008. View Article : Google Scholar
|
|
15
|
Valcourt U, Kowanetz M, Niimi H, Heldin CH
and Moustakas A: TGF-beta and the Smad signaling pathway support
transcriptomic reprogramming during epithelial-mesenchymal cell
transition. Mol Biol Cell. 16:1987–2002. 2005. View Article : Google Scholar
|
|
16
|
Ikushima H and Miyazono K: Biology of
transforming growth factor-β signaling. Curr Pharm Biotechnol.
12:2099–2107. 2011.
|
|
17
|
Xiao J, Xiang Q, Xiao YC, et al: The
effect of transforming growth factor-beta1 on nasopharyngeal
carcinoma cells: insensitive to cell growth but functional to
TGF-beta/Smad pathway. J Exp Clin Cancer Res. 29:352010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hariharan R, Babu JM, PR and Pillai MR:
Mutational analysis of Smad7 in human cervical cancer. Oncol Rep.
21:1001–1004. 2009.PubMed/NCBI
|
|
19
|
Luo X, Xu J and Chegini N: The expression
of Smads in human endometrium and regulation and induction in
endometrial epithelial and stromal cells by transforming growth
factor-beta. J Clin Endocrinol Metab. 88:4967–4976. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shenhua X, Lijuan Q, Hanzhou N, et al:
Establishment of a highly metastatic human ovarian cancer cell line
(HO-8910PM) and its characterization. J Exp Clin Cancer Res.
18:233–239. 1999.PubMed/NCBI
|
|
21
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Drabsch Y and ten Dijke P: TGF-β
signalling and its role in cancer progression and metastasis.
Cancer Metastasis Rev. 31:553–568. 2012.
|
|
23
|
Horiguchi K, Shirakihara T, Nakano A,
Imamura T, Miyazono K and Saitoh M: Role of Ras signaling in the
induction of snail by transforming growth factor-beta. J Biol Chem.
284:245–253. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moustakas A and Heldin CH: Signaling
networks guiding epithelial-mesenchymal transitions during
embryogenesis and cancer progression. Cancer Sci. 98:1512–1520.
2007. View Article : Google Scholar
|
|
25
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: an emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Itóh S, Landström M, Hermansson A, et al:
Transforming growth factor beta1 induces nuclear export of
inhibitory Smad7. J Biol Chem. 273:29195–29201. 1998.PubMed/NCBI
|
|
27
|
Ridley AJ, Schwartz MA, Burridge K, et al:
Cell migration: integrating signals from front to back. Science.
302:1704–1709. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ekman M, Mu Y, Lee SY, et al: APC and
Smad7 link TGFβ type I receptors to the microtubule system to
promote cell migration. Mol Biol Cell. 23:2109–2121.
2012.PubMed/NCBI
|
|
29
|
Pittman AM, Naranjo S, Webb E, et al: The
colorectal cancer risk at 18q21 is caused by a novel variant
altering SMAD7 expression. Genome Res. 19:987–993. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Javelaud D, Mohammad KS, McKenna CR, et
al: Stable overexpression of Smad7 in human melanoma cells impairs
bone metastasis. Cancer Res. 67:2317–2324. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Azuma H, Ehata S, Miyazaki H, et al:
Effect of Smad7 expression on metastasis of mouse mammary carcinoma
JygMC(A) cells. J Natl Cancer Inst. 97:1734–1746. 2005. View Article : Google Scholar
|
|
32
|
Rizzo A, Waldner MJ, Stolfi C, et al:
Smad7 expression in T cells prevents colitis-associated cancer.
Cancer Res. 71:7423–7432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Lee J, Cooley M, Bhogte E, Hartley
S and Glick A: Smad7 but not Smad6 cooperates with oncogenic ras to
cause malignant conversion in a mouse model for squamous cell
carcinoma. Cancer Res. 63:7760–7768. 2003.PubMed/NCBI
|
|
34
|
Halder SK, Beauchamp RD and Datta PK:
Smad7 induces tumorigenicity by blocking TGF-beta-induced growth
inhibition and apoptosis. Exp Cell Res. 307:231–246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gratchev A, Kzhyshkowska J, Kannookadan S,
et al: Activation of a TGF-beta-specific multistep gene expression
program in mature macrophages requires glucocorticoid-mediated
surface expression of TGF-beta receptor II. J Immunol.
180:6553–6565. 2008. View Article : Google Scholar
|
